学会発表(国外)

2018年

  1. Hasegawa T, Hamano T, Wada A, Ito Y, Masakane I. Exchange Ddevices for Peritoneal Dialysis Fluids Use and Peritonitis Incidence: A Nationwide Cohort Study. 55th ERA-EDTA Congress (Copenhagen), 2018 https://doi.org/10.1093/ndt/gfy104.FP479
  2. Hasegawa T, Zhao J, Fuller DS, Zee J, Bieber B, Robinson BM, Pisoni RL, Hanafusa N, Nangaku M. Association Between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis Stimulating Agent Hyporesponsiveness in Haemodialysis Patients with Diabetes Mellitus. 55th ERA-EDTA Congress (Copenhagen), 2018 https://doi.org/10.1093/ndt/gfy104.SP345
  3. Nishiwaki H, Hasegawa T, Hamano T, Masakane I. The Association of the Difference in Hemoglobin Levels Before and After Hemodialysis with the Risk of 1-Year Mortality in Patients Undergoing Hemodialysis: Results from the Japanese Renal Data Registry. J Am Soc Nephrol. 2018; 29: 181 (TH-PO263)
  4. Robinson BM, Vanholder RC, Pisoni RL, Port FK, Morgenstern H, Karaboyasu, A, Li Y, Bieber B, Hakim RM, Hasegawa T, Jadoul MY, Schaeffner E. Estimating the Fraction of First-Year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS. J Am Soc Nephrol. 2018;29: 629 (FR-PO801)
  5. Yajima N, Kamitani T, Saito M, Fukuma S, Koide Y, Okamatsu Y, Araki K, Matsuda Y, Fukuhara S. The association between periodontitis and the disease activity of systemic lupus erythematosus: a cross-sectional study. 83th American College of Rheumatology Annual Meeting (Chicago), 2018 (#1698)

 

2017年

  1. Hasegawa T. DOPPS: Impact of clinical practices on early mortality among HD patients (Symposium 37. Optimizing care in advanced CKD and the transition to dialysis: Insights from DOPPS Program). 54th ERA-EDTA Congress (Madrid), 2017
  2. Nishiwaki H, Hasegawa T, Sasaki S, Minatoguchi S, Furusho M, Kawarazaki H, Uchida D, Miyamoto M, Koitabashi K.A external validation study of the quick sequential organ failure assessment (QSOFA) for Japanese patients undergoing hemodialysis. 54th ERA-EDTA Congress (Madrid), 2017: MP148
  3. Nishiwaki H, Hasegawa T, Tominaga N, Yazawa M, Kawarazaki H, Ikenoue T, Shibagaki Y, Fukuma S, Fukuhara S. Association between Post-Dialysis Hemoglobin Level and the Survival of Vascular Access. J Am Soc Nephrol. 2017; 28: 605 (FR-PO780)
  4. Hanafusa N, Tu C, McCullough K, Bieber B, Pisoni RL, Robinson BM, Hasegawa T, Nangaku M. Evaluation of Gender Differences in the Association between Hemoglobin and Mortality Among Hemodialysed Patients in the JDOPPS. J Am Soc Nephrol. 2017; 28: 884 (SA-PO793)
  5. Yajima N, Sada K, Fukuma S, Tsujimoto Y, Shimizu S, Niihata K, Mimori T, Tanaka Y,  Takeuchi T, Sugiura M, Kohsaka H, Tamura N, Kuwana M, Kameda H, Asano Y, Azuma T, Matsui T, Suzuki K, Takahashi R, Fukuhara S, Atsumi T. Development of a quality indicator set for systemic lupus erythematosus in Japan. 82th American College of Rheumatology Annual Meeting (San Diego), 2017, #1573

 

2016年

  1. Sasaki S, Hasegawa T, Kawarazaki H, Nishiwaki H, Fukuma S, Shibagaki Y, Fukuhara S. Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient Settings. 53th ERA-EDTA Congress (Vienna), 2016: MP618
  2. Hasegawa T, Sakamaki K, Koiwa F, Akizawa T. Clinical Prediction Models for Progression of Chronic Kidney Disease to End Stagae Kidney Failure under Predialysis Nephrology Care: Results from the Chronic Kidney Disease Japan Cohort Study. 53th ERA-EDTA Congress (Vienna), 2016: MP302
  3. Hoshino J, Abe M, Hasegawa T, Hamano T, Wada A, Ubara Y, Takaichi K, Nakai S, Inaba M, Masakane I. Associations between Mortality and Glycemic Control with Glycated Albumin and Hemoglobin A1c in Diabetic Patients on Hemodialysis. J Am Soc Nephrol. 2016; 27: 557A (FR-PO821)
  4. Sakaguchi Y, Hamano T, Wada A, Abe M, Kanda E, Goto S, Hasegawa T, Hoshino J, Kikuchi K, Miyazaki M, Nakai S, Masakane I. Lower Serum Magnesium Levels Are Associated with an Increased Risk of Hip Fracture in Hemodialysis Patients ‑ A Nationwide Cohort Study. J Am Soc Nephrol. 2016; 27: 463A (FR-PO435)
  5. Kovesdy CP, Matsushita K, Sang Y, Carrero JJ, Chodick G, Hasegawa T, Hirayama A, Ishani A, Landman G, Levin A, Major1 R, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams M. CKD Prognosis Consortium. Serum Potassium and the Risk of Adverse Outcomes: A CKD Prognosis Consortium Meta-Analysis. J Am Soc Nephrol. 2016; 27: 201A (TH-PO475)